These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1353705)

  • 1. Monoclonal antibody MRK16 reverses the multidrug resistance of multidrug-resistant transgenic mice.
    Mickisch GH; Pai LH; Gottesman MM; Pastan I
    Cancer Res; 1992 Aug; 52(16):4427-32. PubMed ID: 1353705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy and chemosensitization of transgenic mice which express the human multidrug resistance gene in bone marrow: efficacy, potency, and toxicity.
    Mickisch GH; Licht T; Merlino GT; Gottesman MM; Pastan I
    Cancer Res; 1991 Oct; 51(19):5417-24. PubMed ID: 1680550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model.
    Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K
    Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas exotoxin conjugated to monoclonal antibody MRK16 specifically kills multidrug resistant cells in cultured renal carcinomas and in MDR-transgenic mice.
    Mickisch GH; Pai LH; Siegsmund M; Campain J; Gottesman MM; Pastan I
    J Urol; 1993 Jan; 149(1):174-8. PubMed ID: 8417204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance.
    Leveille-Webster CR; Arias IA
    Clin Cancer Res; 1996 Apr; 2(4):695-706. PubMed ID: 9816220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
    Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
    Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
    Van Acker KL; Van Hove LM; Boogaerts MA
    Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the multidrug resistance-associated protein (MRP) gene in vincristine but not doxorubicin-selected multidrug-resistant murine erythroleukemia cells.
    Slapak CA; Fracasso PM; Martell RL; Toppmeyer DL; Lecerf JM; Levy SB
    Cancer Res; 1994 Nov; 54(21):5607-13. PubMed ID: 7923205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
    Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
    Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
    Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
    Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies.
    Schinkel AH; Roelofs EM; Borst P
    Cancer Res; 1991 May; 51(10):2628-35. PubMed ID: 1673638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
    Kühl JS; Sikic BI; Blume KG; Chao NJ
    Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal by cefoperazone of resistance to etoposide, doxorubicin, and vinblastine in multidrug resistant human sarcoma cells.
    Gosland MP; Lum BL; Sikic BI
    Cancer Res; 1989 Dec; 49(24 Pt 1):6901-5. PubMed ID: 2582432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin.
    Mirski SE; Gerlach JH; Cole SP
    Cancer Res; 1987 May; 47(10):2594-8. PubMed ID: 2436751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circumvention of the intrinsic multidrug-resistance in renal cell carcinoma].
    Kakehi Y; Segawa T; Hashimura T; Yoshida O
    Hinyokika Kiyo; 1992 Nov; 38(11):1319-24. PubMed ID: 1485588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ; Rodarte JC; Benbatoul KD; Romano SJ; Zhang C; Krane S; Moran EJ; Uyeda RT; Dixon R; Guns ES; Mayer LD
    Cancer Res; 2000 Jun; 60(11):2964-72. PubMed ID: 10850444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16.
    Ishida Y; Ohtsu T; Hamada H; Sugimoto Y; Tobinai K; Minato K; Tsuruo T; Shimoyama M
    Jpn J Cancer Res; 1989 Oct; 80(10):1006-13. PubMed ID: 2575608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
    Yang JM; Goldenberg S; Gottesman MM; Hait WN
    Cancer Res; 1994 Feb; 54(3):730-7. PubMed ID: 7905786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha.
    Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F
    Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 17 beta-estradiol glucuronide: an inducer of cholestasis and a physiological substrate for the multidrug resistance transporter.
    Gosland M; Tsuboi C; Hoffman T; Goodin S; Vore M
    Cancer Res; 1993 Nov; 53(22):5382-5. PubMed ID: 8106146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.